HexemBio
PrivateLast Round
Seed
Apr 7, 2026
Total Funding Raised
$10.4M
Momentum Score
50 /100
Company Overview
HexemBio is a biotechnology company pioneering the world's first blood stem cell rejuvenation therapy to reverse aging and improve healthspan.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HexemBio Comps
Public and private peers based on sector, stage, and business model.
HexemBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 7, 2026 |
HexemBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Seed |
| Venture Science | Seed |
| Gaingels | Seed |
| Treeo VC | Seed |
| ZAKA VC | Seed |
| Innovation Works | Seed |
| E2MC Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 267% QoQ from 3 to 11 employees.
- Apr 7, 2026
$10.4M raised in Seed round.
HexemBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HexemBio's valuation, stock price, and market status.
